PROPHYLAXIA AS

6392 VIKEBUKT

Finances

Return on Equity

20,64 %

Current Ratio

0,82

Debt-to-Equity Ratio

7,06

Key figures (NOK)	2022	2021	2020	2019
Revenue	77 061 000	178 320 000	48 356 000	84 395 000
Net Income	6 519 000	37 334 000	9 083 000	24 145 000
Total Assets	409 526 000	119 580 000	140 179 000	66 393 000
Total Equity	31 583 000	25 065 000	17 730 000	18 648 000

Income (NOK)	2022	2021	2020	2019
Revenue	77 061 000	178 320 000	48 356 000	84 395 000
Expenditure	100 174 000	95 874 000	81 947 000	46 439 000
Operating Profit	11 814 000	48 656 000	12 174 000	31 610 000
Financial Income	1 344 000	657 000	278 000	200 000
Financial Costs	4 826 000	1 576 000	1 098 000	965 000
Financial Balance	−3 482 000	−919 000	−820 000	−765 000
Earnings Before Tax	8 333 000	47 737 000	11 354 000	30 845 000
Tax	1 814 000	10 403 000	2 271 000	6 700 000
Net Income	6 519 000	37 334 000	9 083 000	24 145 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	282 576 000	33 018 000	20 046 000	27 674 000
Total Current Assets	126 949 000	86 562 000	120 132 000	38 719 000
Total Assets	409 526 000	119 580 000	140 179 000	66 393 000
Total Retained Equity	30 230 000	23 711 000	16 377 000	17 294 000
Total Equity	31 583 000	25 065 000	17 730 000	18 648 000
Total Long-Term Debt	223 006 000	1 672 000	7 391 000	7 968 000
Total Current Debt	154 936 000	92 844 000	115 057 000	39 777 000
Total Equity and Debt	409 526 000	119 580 000	140 179 000	66 393 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	76 826 000	177 823 000	48 356 000	84 395 000
Other Income	235 000	496 000	0	0
Revenue	77 061 000	178 320 000	48 356 000	84 395 000
Cost of Goods Sold	76 527 000	73 214 000	58 007 000	31 336 000
Salary Costs	7 621 000	6 728 000	4 925 000	3 864 000
Depreciation	2 039 000	1 963 000	1 539 000	1 321 000
Impairment	0	0	0	0
Expenditure	100 174 000	95 874 000	81 947 000	46 439 000
Operating Profit	11 814 000	48 656 000	12 174 000	31 610 000
Financial Income	1 344 000	657 000	278 000	200 000
Financial Costs	4 826 000	1 576 000	1 098 000	965 000
Financial Balance	−3 482 000	−919 000	−820 000	−765 000
Dividends	0	30 000 000	10 000 000	20 000 000
Net Income	6 519 000	37 334 000	9 083 000	24 145 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	241 927 000	0	0	0
Real Eastate	3 806 000	1 746 000	200 000	0
Machinery and Plant Facilities	3 145 000	4 707 000	4 418 000	4 618 000
Fixtures	279 000	118 000	120 000	255 000
Total Tangible Assets	7 253 000	6 571 000	4 738 000	4 873 000
Total Fiancial Fixed Assets	33 396 000	26 448 000	15 308 000	22 801 000
Total Fixed Assets	282 576 000	33 018 000	20 046 000	27 674 000
Stock	67 274 000	32 349 000	66 139 000	20 435 000
Total Investments	0	0	0	0
Cash, Bank	500 000	436 000	228 000	796 000
Total Current Assets	126 949 000	86 562 000	120 132 000	38 719 000
Total Assets	409 526 000	119 580 000	140 179 000	66 393 000
Total Equity	31 583 000	25 065 000	17 730 000	18 648 000
Short-Term Group Debt	0	126 000	0	0
Total Long-Term Debt	223 006 000	1 672 000	7 391 000	7 968 000
Creditors	38 112 000	16 135 000	31 614 000	8 834 000
Unpaid Taxes	1 374 000	4 469 000	362 000	2 351 000
Dividends	0	30 000 000	10 000 000	20 000 000
Other Current Debt	83 379 000	12 692 000	39 209 000	1 599 000
Total Current Debt	154 936 000	92 844 000	115 057 000	39 777 000
Total Equity and Debt	409 526 000	119 580 000	140 179 000	66 393 000

Financial indicators	2022	2021	2020	2019
Return on Equity	20,64 %	148,95 %	51,23 %	129,48 %
Debt-to-Equity Ratio	7,06	0,07	0,42	0,43
Operating Profit Margin	15,33 %	27,29 %	25,18 %	37,45 %
Current Ratio	0,82	0,93	1,04	0,97
Quick Ratio	1,45	1,43	2,46	2
Equity Ratio	0,08	0,21	0,13	0,28
Gross Profit Margin	0,69 %	58,94 %	−19,96 %	62,87 %